29th Jul 2019 11:50
LONDON (Alliance News) - Yourgene Health PLC, which develops treatment for Down's syndrome and other genetic disorders, said Monday that it has appointed John Brown as non-executive director with immediate effect.
Brown- who will act as senior independent director on the board - is currently a senior independent director of Biocity and Acacia Pharma and is chairman of Cell Therapy Catapult and Synpromics. His has previous board experience with roles including Chairman of Axis-Shield, Chairman of BTG, Non-executive Director of Vectura and Chief Executive Officer of Acambis.
Chairman Adam Reynolds said: "We are delighted to welcome John to the Board of Yourgene. John has unrivalled experience in working with publicly listed life sciences businesses and we look forward to drawing on his experience as we drive awareness of Yourgene's expanded product portfolio across our target markets. John's skillset and experience is a great strategic fit as Yourgene enters the next phase of its growth journey."
Shares in Yourgene were 2.1% lower on Monday morning at 11.40 pence each
Related Shares:
YGEN.L